Process for the preparation of 2'-HALO-$G(B)-L-arabinofuranosyl nucleosides
Details for Australian Patent Application No. 2002303187 (hide)
International Classifications
Event Publications
12 December 2002 Complete Application Filed
Priority application(s): 60/280,307 30.03.01 US
3 April 2003 Application Open to Public Inspection
Published as AU-B-2002303187
17 June 2004 Assignment before Grant
Triangle Pharmaceuticals, Inc. The application has been assigned to Gilead Sciences, Inc.
14 December 2006 Assignment before Grant
Gilead Sciences Inc The application has been assigned to Bukwang Pharmaceutical Company Ltd,
8 November 2007 Application Accepted
Published as AU-B-2002303187
24 January 2008 Application for Amendment
The nature of the amendment is as shown in the statement(s) filed 04 Jan 2008. Address for service in Australia - Davies Collison Cave 1 Nicholson Street Melbourne VIC 3000
6 March 2008 Standard Patent Sealed
12 June 2008 Amendment Made
The nature of the amendment is as shown in the statement(s) filed 04 Jan 2008
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
2002303188-TRANSGENIC MICE CONTAINING KALLIKREIN-LIKE GENE DISRUPTIONS
2002303186-SYSTEM FOR VISUAL PREFERENCE DETERMINATION AND PREDICTIVE PRODUCT SELECTION
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
![](/images/main/3dbox_small.png)
- Editable Word format reports
- For IP Professionals
- Multiuser